Clinical trials
Clinical clinical trials
Below are recruiting clinical clinical trials, each written for real people, not researchers. We’re tracking 5,437 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06841328Recruiting
Stem cell therapy for fertility in ovaries and testes
This study tests a regenerative stem cell therapy to improve fertility in men with testicular failure or low sperm count and women with early ovarian failure. It is for people who have already tried standard treatments without success.
Dubai, DubaiAges 20–50 - NCT06760364RecruitingPhase 1
CHT102 for Advanced Pancreatic Cancer with Mesothelin
This trial tests a new treatment called CHT102 for people with advanced pancreatic cancer that has a specific protein (mesothelin) on their tumor cells. It's for those who have already tried standard treatments without success or couldn't tolerate them.
TianjinAges 18–70 - NCT05365672RecruitingPhase 2
Donor immune cell therapy during live kidney transplant
This Phase 2 trial studies a treatment using immune cells made from your living donor, given around the time of kidney transplant. It aims to improve transplant safety and outcomes by adjusting the immune response to the new kidney.
BerlinAges 18–69 - NCT05196906Recruiting
Compare ankle stabilization surgery techniques for ligament injury
This trial compares two ways to surgically stabilize an ankle that feels unstable and causes pain. It may help patients by identifying which technique leads to better ankle function and outcomes.
BeijingAges 18–60 - NCT06685887RecruitingPhase 2
Chemo, Immunotherapy, and Heated Belly Chemo for Stomach Cancer Spread
This trial tests combining standard chemotherapy and immunotherapy (tirelizumab) with heated chemotherapy given directly into the belly. It aims to treat stomach cancer that has spread to the abdominal lining, and may help shrink or control the cancer.
Wuhan, HubeiAges 18–75 - NCT06924099Recruiting
Study of Optune in newly diagnosed GBM patients
This study follows patients with newly diagnosed glioblastoma who are receiving maintenance chemotherapy and starting treatment with the Optune device. It aims to see how well the device works in routine care.
AmiensAges 18 years+ - NCT06923150Recruiting
MiniGo vs. standard care for bowel symptoms after rectal cancer surgery
This trial tests a small, portable device called MiniGo that uses a gentle water rinse to help control bowel symptoms after rectal cancer surgery. It may be an option for people who still have bothersome bowel problems despite trying other treatments.
AmiensAges 18 years+ - NCT06094556RecruitingPhase 1
A study of SHR-1826 for advanced solid tumors
This trial tests a new drug called SHR-1826 for people with advanced solid tumors that have not responded to or are no longer helped by standard treatments. It is an early-phase study (Phase 1) to see if the drug is safe and how well it works.
Guangzhou, GuangdongAges 18–75 - NCT07209111RecruitingPhase 2
Testing Calderasib for advanced solid tumors with KRAS G12C mutation
This trial tests a new drug, Calderasib (MK-1084), for people with advanced solid tumors that have a specific KRAS G12C mutation and aren't getting better with standard treatments. The goal is to see if the drug can help shrink or control the cancer.
Baltimore, MarylandAges 18 years+ - NCT07205328RecruitingPhase 2
Testing MT200605 for acute ischemic stroke
This trial tests whether MT200605 can help people who recently had an ischemic stroke (a type of stroke caused by a blocked blood vessel). The drug is given within 24 hours of symptoms starting, and you may join even if you received clot-busting treatment already.
Beijing, Beijing MunicipalityAges 18–80 - NCT07205198RecruitingPhase 1
Study of SIBP-A10 for advanced solid tumors
This trial tests a new drug called SIBP-A10 for people with advanced cancer that has not responded to other treatments. It aims to see if the drug is safe and helps shrink tumors.
Dalian, LiaoningAges 18–75 - NCT07209033Recruiting
Testing FlexiOss for bone repair in leg and foot fractures
This trial tests a new material called FlexiOss to help heal broken bones in the leg or foot. It aims to see if the material is safe and effective for bone regeneration.
KrakowAges 18–75 - NCT07207070RecruitingPhase 3
New drug combination for PIK3CA-mutated breast cancer
This trial tests a new combination of two drugs (JS105 plus dalpiciclib and fulvestrant) against a standard combination (dalpiciclib plus fulvestrant) for people whose breast cancer has a PIK3CA mutation. The goal is to see if adding JS105 helps control the cancer longer.
Beijing, Beijing MunicipalityAges 18–75 - NCT07205315RecruitingEarly Phase 1
Testing GT801 cell therapy for blood cancer and AIHA
This study tests an investigational cell therapy called GT801 for people whose CD19-positive blood cancer (B-ALL, CLL, or B-NHL) or autoimmune hemolytic anemia (AIHA) has not responded to standard treatments. The therapy is made from your own immune cells, modified to target and destroy cancer cells or abnormal immune cells.
Zhengzhou, HenanAges 18–75 - NCT07208058RecruitingPhase 3
Testing plonmarlimab for blood cell overactivation in people with rheumatic disease
This trial tests a new drug called plonmarlimab for people with a rheumatic (joint or immune) disease who also have a dangerous overreaction of their immune system called HLH (or MAS). The goal is to see if the drug can help when high-dose steroids have not worked or are not an option.
Beijing, Beijing MunicipalityAges 16–80 - NCT07203755RecruitingPhase 1
Combination vaccine for whooping cough, Hib, and meningitis
This trial tests a new combination vaccine that protects against whooping cough, Haemophilus influenzae type b (a cause of meningitis and pneumonia), and several types of meningococcal disease (a cause of meningitis and bloodstream infections). It may help reduce the number of shots needed for children.
Shangqiu, HenanAges 2 months–6 years - NCT06924944Recruiting
A study of a new lens for people who had laser eye surgery
This study looks at how well a type of artificial lens (Clareon Vivity) works for people who have had laser eye surgery in the past and now need cataract surgery. It aims to see if this lens gives good vision without glasses.
Ogden, UtahAges Any age - NCT06837246Recruiting
Nutritional supplement study for cognitive health in adults
This study tests whether a nutritional supplement taken as 3 capsules daily for 12 weeks can improve cognitive function. It is designed for generally healthy adults who do not have certain medical conditions or take certain medications.
Addison, IllinoisAges 25–65 - NCT05738252Recruiting
Frailty tests to assess surgical risk in gynecologic cancers
This trial studies simple “frailty” assessments (tests of strength, memory, and daily functioning) to better predict risk in people with gynecologic cancers who are planning or having surgery. If you qualify, the results may help doctors identify who needs extra support before and after surgery.
Hamilton, OntarioAges 55–110 - NCT07207057RecruitingPhase 3
Platform trial testing multiple drugs for Parkinson's disease
This trial tests several experimental drugs at once to find new treatments for Parkinson's disease. If you have Parkinson's and take medication, you may be able to join and help speed up research.
LondonAges 30 years+ - NCT07210437Recruiting
Autonomic changes and health problems after spinal cord injury
This study looks at how the autonomic nervous system (which controls things like heart rate and blood pressure) changes after a spinal cord injury. It aims to predict later health problems.
Rochester, MinnesotaAges 18–75 - NCT07203339Recruiting
Home brain stimulation vs. duloxetine for fibromyalgia pain
This trial compares a non-invasive, at-home brain stimulation technique (tDCS) to the medication duloxetine for treating fibromyalgia pain. It aims to see if the brain stimulation works as well as the drug.
Porto Alegre, Rio Grande do SulAges 18–75 - NCT07205393Recruiting
Heart rehab after valve replacement surgery
This trial tests a phase one cardiac rehabilitation program for people who have had their mitral or aortic heart valve replaced. It aims to see if the rehab helps recovery. You might qualify if you had planned (not emergency) valve surgery and are stable enough for light exercise.
QinaAges 40–55 - NCT07212049Enrolling by invitation
Ultrasound to measure magnetic growing rods
This study tests if ultrasound can accurately measure the length of magnetically controlled growing rods used in leg bone lengthening. It may help doctors monitor treatment without extra X-rays.
Orlando, FloridaAges 8–21
Hear when a new Clinical trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for clinical?
- Yes. Clin2 currently lists 5,437 recruiting clinical studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a clinical trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a clinical trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.